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The effect of pentobarbital anesthesia upon the minimal voltage and current required for 
electrical ventricular defibrillation (the defibrillation threshold) was investigated in dogs. 
Threshold current, energy, and charge in five dogs averaged 2 per cent, 13 per cent, and 6 per 
cent less under surgical levels of pentobarbital anesthesia than thresholds in the same animals in 
the awake, unanesthetized state. In dogs given sufficient pentobarbital to produce apnea and 
supported by mechanical ventilation, threshold current, energy, and charge averaged 3 per cent, 
17 per cent, and 2 per cent less than comparable awake values. These differences were far from 
statistically significant. In a second study, five dogs were kept for 8 to 10 hours at a surgical 
level of anesthesia with pentobarbital sodium. Defibrillation threshold current, determined at 
hourly intervals, did not drift outside ± 10 per cent limits. Arterial blood gas measurements 
revealed a stable, compensated metabolic acidosis in all animals (pH 7.36 ± 0.06, pCO2 33 ± 4 
mm. Hg, pO2 71 ± 9 mm. Hg). These data support the validity of defibrillation studies using 
animals anesthetized with pentobarbital and indicate the stability of the defibrillation threshold 
under controlled experimental conditions. 
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Electric shock applied across the chest or directly to the heart is the only practicable means for 
termination of ventricular fibrillation, an otherwise lethal cardiac arrhythmia. [1]  The shock 
strength required for defibrillation of the ventricles depends upon body weight in animals and in 
man, [2-5] but also may be influenced by physiologic factors such as myocardial ischemia, 
electrolyte imbalance, drug action, and body temperature. [6-8]  Knowledge of the factors which 
determine the shock strength necessary for defibrillation is important because a shock which is 
too weak may fail to defibrillate, and a shock which is too strong may damage the heart. [9-10]  
All controlled experimental studies of electrical ventricular defibrillation reported to date have 
used anesthetized animals as subjects--in most cases barbiturate anesthetized dogs. In contrast, 
virtually all clinical ventricular defibrillations outside the operating room are carried out in 
unanesthetized patients in settings such as the coronary care unit or emergency room. Recently 
the barbiturate anesthetized dog has been criticized as a model of normal cardiovascular 
physiology. [11]  Since no study can be found in the literature reporting the influence of 
anesthesia on the efficacy of electrical defibrillation, a reasonable question may be raised about 
the validity of anesthetized animal models used for defibrillation studies. 
 
The author has reviewed 58 reports, dated 1899 to 1975, concerning the efficacy of electric 
shock for the termination of cardiac fibrillation in animals. In only one study was no anesthesia 
employed routinely. In 37 of 58 studies injectable pentobarbital sodium was the only anesthetic 
used in a particular species. In 10 of the studies thiopental sodium was employed, either alone or 
in combination with inhalation anesthetics and muscle relaxants. In six of the studies a mixture 
of halothane, nitrous oxide, and oxygen was used, often after the induction of anesthesia with 
intravenous thiopental sodium. The use of a variety of other anesthetic agents for defibrillation 
studies has been reported, including sodium barbital, glycerol guaiacolate, morphine, and 
chloralose. In 52 of the 58 studies dogs were used as experimental subjects. In particular the 
pentobarbital anesthetized dog was used in 36 (62 per cent) of the defibrillation studies.  
 
Unquestionably, anesthetic agents of all kinds have direct effects upon excitable biologic 
membranes. Although the central nervous system is the most important site of action of general 
anesthetic agents, many anesthetics, including pentobarbital, are known to affect the mechanical 
and electrical performance of cardiac muscle. The amplitude and strength of myocardial 
contraction are depressed by cyclopropane, diethyl ether, nitrous oxide, and halothane, as well as 
by barbiturates including pentobarbital, secobarbital, and thiopental. [12-16]  Hydrocarbon 
anesthetics may depress the rate of activity of the sinus node pacemaker as well as the speed of 
AV and intraventricular conduction. [13, 17]  Significant differences in the response of the dog 
heart to the AV blocking and arrhythmogenic actions of digitalis glycosides have been reported 
for animals anesthetized with pentobarbital vs. halothane, vs. methoxyflurane. [18]  
Cyclopropane, halothane, and to a lesser extent thiopental are known to sensitize the 
myocardium to the arrhythmogenic effects of epinephrine. [19]  Accordingly, it is quite 
conceivable that anesthetics could alter those parameters of cardiac electrophysiology which 




It is generally accepted that during the induction of anesthesia the relative lipid solubility of 
general anesthetics and the generous blood flow to the brain cause initial concentration of these 
drugs in the central nervous system. After maintenance of anesthesia for several minutes to 
several hours, however, these drugs become widely redistributed in peripheral tissues, including 
the myocardium. [20-22]  If there were a significant effect of anesthetics upon the determinants 
of electrical defibrillation, one might reasonably expect a gradual drift of the threshold voltage 
and current for defibrillation over the course of experiments using anesthetized animals as 
subjects. Control studies demonstrating the presence or absence of such a drift in defibrillation 
threshold over time intervals greater than one hour have not been reported to date. Accordingly, 
the following studies were undertaken to determine (1) if the induction of anesthesia with 
intravenous pentobarbital sodium in the dog alters transchest defibrillation threshold, and (2) if 
the maintenance of a stable surgical level of anesthesia with pentobarbital sodium for 8 to 10 





Study 1. Effect of pentobarbital anesthesia. 
 
Five dogs of mixed breed, weighing 6 to 14 kilo grams, served as subjects. Initially each dog was 
anesthetized with injectable pentobarbital sodium (Nembutal, 50 mg./ml. in a 10 per cent 
alcohol, 40 per cent propylene glycol vehicle, 25 to 30 mg./Kg. intravenously). No preanesthetic 
medication was given. A bipolar catheter electrode was placed in the right ventricle of the heart 
via a right jugular venous cut-down, using sterile technique. Position of the catheter electrode 
within the heart was verified by recording the catheter tip electrogram and comparing its timing 
with the electrocardiogram (ECG) Lead II. The catheter was stabilized in the jugular vein and the 
wound was closed with 2-0 silk sutures. The external portion of the catheter was protected with 
an adhesive elastic bandage placed around the neck and a soft collar 8 cm. in width.  
 
After a recovery period of 36 to 72 hours the defibrillation threshold was determined before and 
after induction of anesthesia with pentobarbital. These investigations in unanesthetized and 
anesthetized subjects were carried out in accordance with National Institutes of Health and 
institutional guidelines for the use of laboratory animals. [3, 24].  Defibrillation threshold in 
awake, unrestrained animals was measured as follows: ECG Lead II electrodes were applied to 
the limbs and the position of the catheter electrode was confirmed by recording the catheter tip 
electrogram. Defibrillating electrodes, held in position with rubber straps, were applied to the 
shaved skin of the thorax with electrolytic jelly, one centered over the apex beat area and the 
other in the opposite position on the right chest wall. The defibrillating electrodes were stainless 
steel discs, 2 mm. thick and 8 to 10 cm. in diameter (20 per cent of the animal's chest 
circumference ± 1cm.). The standard location of each electrode was outlined in ink on the thorax. 
 
Ventricular fibrillation was produced by the application of a 1 second train of 60 Hz, 2 msec. 
duration rectangular electrical pulses of 5 to 15 volts intensity via the right ventricular catheter. 
Ventricular fibrillation was confirmed by the presence of random waves in the electrocardiogram 
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and by the descending level of consciousness of the subject. As the animal lost consciousness it 
was placed in dorsal recumbency. 
 
The defibrillator employed contained a 16 microfarad capacitance, a 44 milihenry inductance, 
and a 7 ohm internal resistance in series with the subject. A 1.00 ohm, 100 watt resistor in series 
with one electrode was used for measuring current output. The peak output voltage of the 
defibrillator could be varied continuously from 0 to 7,000 volts. The duration of the delivered 
current pulse, slightly dependent upon subject resistance, was typically 4 to 5 msec. The wave- 
form of the current pulse was a heavily damped sinusoid. 
 
As soon as possible after the confirmation of ventricular fibrillation, (15 to 45 seconds after 
endocardial stimulation), a defibrillator shock, calculated to be adequate for defibrillation on the 
basis of the dog's body weight as described by Geddes and colleagues [2] was delivered at the 
time of end-expiration. The voltage and current applied to the subject were measured using a 
Tektronics model D-11 dual channel storage oscilloscope. Defibrillation was confirmed by return 
of the femoral pulse and QRS complexes in the electrocardiogram. With return of consciousness 
the animal was allowed to right itself. After a recovery period of about 2 minutes, the heart was 
refibrillated and defibrillation was attempted with a voltage setting 5 to 10 per cent less than that 
of the previous trial. This procedure was repeated until the animal was not defibrillated by the 
first shock, whereupon a stronger shock was applied immediately to restore cardiac pumping 
action.  
 
Threshold voltage and current were defined as the lowest values able to defibrillate the 
ventricles. Only data from the first shock delivered after the onset of fibrillation were used in 
calculation of threshold. In this study threshold values were considered adequately precise if they 
differed no more than 10 per cent from values unable to defibrillate the ventricles. Delivered 
energy and charge were calculated as described by Babbs and Whistler. [25]  Twenty minutes 
after the defibrillation threshold was determined in the unanesthetized animal, intravenous 
pentobarbital sodium (25 to 30 mg./Kg.), was given to produce surgical anesthesia and the 
defibrillation threshold measurement was repeated with the animal in dorsal recumbency.  After 
a three day recovery period, another set of threshold determinations was made in the awake and 
anesthetized states. 
 
On the final day of testing, the defibrillation threshold was determined following larger doses of 
pentobarbital. After the routine threshold determination under surgical anesthesia, sufficient 
intravenous pentobarbital was given to produce apnea and the threshold measurement was 
repeated. Then sufficient intravenous pentobarbital was given to produce circulatory shock 
(defined as systolic blood pressure less than 50 mm. Hg measured via a catheter placed in the 
abdominal aorta) and a final threshold determination made within 10 minutes. During apnea and 
shock the animal was maintained using mechanical ventilation sufficient to produce a respiratory 






Study 2. Stability of defibrillation threshold under pentobarbital anesthesia. 
 
Five dogs of mixed breed, 5 to 16 kilograms in weight, conditioned in captivity for a period of at 
least two weeks, and disease-free by physical examination, were used in this study. Each animal 
was anesthetized with intravenous pentobarbital sodium (25 to 30 mg./Kg.). No other drug, 
except normal saline, was administered at any time. The trachea was intubated and the animal 
placed in dorsal recumbency for the duration of the study. The urinary bladder was catheterized 
with a No. 8 French filiform catheter connected to a closed volumetric drainage bottle. Mean 
aortic blood pressure was measured using a mercury manometer, and respiratory minute volume 
was measured with a Wright respirometer. Arterial blood pH, pCO2, and pO2 were monitored 
using an Instrumentation Laboratories Model 213 blood gas analyzer. Disc electrodes of 8, 10, or 
12 cm. in diameter (20 per cent of the chest circumference ± 1 cm.) were applied to the shaved 
skin of the right and left hemithoraces with electrolytic jelly and sutured in place. One electrode 
was centered over the apex beat of the heart and the other was located at a corresponding 
position on the right chest wall, 3 cm. cephalad of the left electrode. Defibrillation threshold was 
determined once every hour using the method described for Study 1. The values of mean aortic 
blood pressure, respiratory minute volume, urine output, arterial blood gases, and esophageal 
temperature were recorded at half-hour intervals. A stable level of surgical anesthesia was 
maintained in each animal by the intravenous administration of 2 to 5 mg./Kg. maintenance 
doses of pentobarbital sodium each hour. Saline solution, 0.9 per cent, was given in quantities of 
1 to 2 ml./Kg./hr. by vein. Esophageal temperature was maintained in the range of 36 to 39° C. 





Study 1. Effect of pentobarbital anesthesia. 
 
In all five dogs comparisons could be made between defibrillation thresholds in the awake and 
the anesthetized states. In one dog, three successive comparisons of awake vs. anesthetized 
threshold values were made during a 12-day period. Threshold current data for this animal are 
plotted in Fig. 1. The ratios of the threshold peak current for all dogs at all levels of anesthesia to 
the average threshold under surgical anesthesia for each animal, are plotted in Fig. 2. No 
consistent effect of pentobarbital anesthesia on the ventricular fibrillation threshold is evident.  
Mean values of threshold shock strength (on the final day of testing) in terms of peak current, 
delivered energy, and delivered charge per kilogram of body weight are given in Table I. One-
way analyses of variance indicate that the observed effects of anesthesia level upon threshold 







Fig. 1. Threshold peak current for ventricular defibrillation in unanesthetized and 
anesthetized states on successive trials in the same animal. On three successive trials 
the threshold current in the unanesthetized animal was greater than, equal to, and less 
than the threshold current after induction of pentobarbital anesthesia. Mean threshold 
before anesthesia = 1.02 A/Kg; mean threshold after anesthesia = 1.08 A/Kg. 











The response of unanesthetized dogs to the fibrillation-defibrillation procedure is worthy of 
mention. Typically, the dogs were not alarmed by the intracardiac electrical stimulation used to 
induce fibrillation. The loss of cerebral blood Bow due to ventricular fibrillation produced initial 
excitation, lasting 5 to 15 seconds, which rapidly diminished as the animal lost consciousness. 
Delivery of defibrillating current caused a brief, forceful contraction of thoracic and abdominal 
musculature, resulting in vocalization. Animals for whom the total circulatory arrest time was 
less than 30 seconds rapidly regained consciousness, and assumed a sitting or standing position. 
Animals for whom the total circulatory arrest time was 30 to 60 seconds did not regain 
consciousness as soon after defibrillation. These animals remained in dorsal recumbency after 







Fig. 2. Relative values of threshold peak current for ventricular defibrillation at four 
levels of anesthesia. Awake = no anesthesia, surgical anesthesia = spontaneous 
respiration but no response to surgical stimulation (25 to 30 mg./Kg. pentobarbital), 
apnea = no spontaneous respiration (42 to 51 mg./Kg. pentobarbital, cumulative dose), 
shock = aortic blood pressure less than 50 mm. Hg systolic (61 to 77 mg./Kg. 
pentobarbital, cumulative dose). Mean threshold current under surgical anesthesia = 
1.0 for each animal. Dog 1, solid circles; Dog 2, solid triangles; Dog 3, open circles; 




Study 2. Stability of defibrillation threshold during anesthesia.  
 
Fig. 3 shows the relative threshold current values for five pentobarbital anesthetized dogs as a 
function of the duration of anesthesia. Relative threshold values were obtained by dividing each 
threshold current by the mean threshold value for a particular animal. No upward or downward 
drift of the threshold current is evident. The variation of individual threshold values seldom 
exceeds ± 10 per cent limits, indicated by dotted lines. Interestingly, the two extreme points in 
Fig. 2 (Dog 4, arrows) were associated with a bout of acute respiratory failure (arterial blood 
gases: pH 7.10, pCO2 54 mm. Hg, pO2 39 mm. Hg); after the institution of mechanical 
ventilation in this animal the threshold returned to control levels. With the exception of this 
incident all dogs exhibited a stable, compensated metabolic acidosis. Arterial blood pH, pCO2, 
9 
 
and pO2 averaged 7.36 ± 0.06,* 33 ± 3.7,* and 71 ± 9,* respectively. Mean arterial blood 
pressure, respiratory minute volume, and urine output were stable during the 8 to 10 hours of 
pentobarbital anesthesia in all five animals, averaging 127 ± 20* mm. Hg, 457 ± 168* 





Fig. 3. Stability of ventricular defibrillation threshold during pentobarbital anesthesia 
in dogs. Mean threshold current = 1.0 for each animal. Arrows indicate threshold 





The data of Studies 1and 2 indicate that the ventricular defibrillation threshold is negligibly 
affected by either the induction or the maintenance of anesthesia with pentobarbital sodium. This 
finding is important because so many experimental studies of electrical defibrillation have been 
carried out in anesthetized animals, whereas in most clinical situations electrical defibrillation is 
attempted in unanesthetized humans. In view of these results the extrapolation of much hard- 
won animal data to the human situation may be made with significantly greater assurance. In the 
absence of surgical or pharmacological intervention, defibrillation threshold is a stable and 
reproducible parameter in the pentobarbital-anesthetized dog. Demonstration of such a stable 
baseline paves the way for further studies of drug effects in ventricular defibrillation, in the 
presence or absence of myocardial ischemia, and for experimental evaluation of alternative 
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